S&P 500   4,561.76 (-0.13%)
DOW   35,972.66 (+0.06%)
QQQ   387.18 (-0.42%)
AAPL   190.27 (+0.17%)
MSFT   372.29 (-1.75%)
META   321.18 (-1.82%)
GOOGL   130.86 (-1.26%)
AMZN   146.09 (+0.00%)
TSLA   234.28 (-2.42%)
NVDA   465.42 (-0.49%)
NIO   7.07 (-2.75%)
BABA   72.90 (-2.64%)
AMD   119.44 (-1.42%)
T   16.68 (+0.66%)
F   10.44 (+1.75%)
MU   76.03 (-0.12%)
CGC   0.56 (+0.34%)
GE   122.89 (+0.89%)
DIS   92.22 (-0.51%)
AMC   6.80 (+2.26%)
PFE   28.99 (-4.86%)
PYPL   58.28 (+1.16%)
XOM   103.69 (+0.92%)
S&P 500   4,561.76 (-0.13%)
DOW   35,972.66 (+0.06%)
QQQ   387.18 (-0.42%)
AAPL   190.27 (+0.17%)
MSFT   372.29 (-1.75%)
META   321.18 (-1.82%)
GOOGL   130.86 (-1.26%)
AMZN   146.09 (+0.00%)
TSLA   234.28 (-2.42%)
NVDA   465.42 (-0.49%)
NIO   7.07 (-2.75%)
BABA   72.90 (-2.64%)
AMD   119.44 (-1.42%)
T   16.68 (+0.66%)
F   10.44 (+1.75%)
MU   76.03 (-0.12%)
CGC   0.56 (+0.34%)
GE   122.89 (+0.89%)
DIS   92.22 (-0.51%)
AMC   6.80 (+2.26%)
PFE   28.99 (-4.86%)
PYPL   58.28 (+1.16%)
XOM   103.69 (+0.92%)
S&P 500   4,561.76 (-0.13%)
DOW   35,972.66 (+0.06%)
QQQ   387.18 (-0.42%)
AAPL   190.27 (+0.17%)
MSFT   372.29 (-1.75%)
META   321.18 (-1.82%)
GOOGL   130.86 (-1.26%)
AMZN   146.09 (+0.00%)
TSLA   234.28 (-2.42%)
NVDA   465.42 (-0.49%)
NIO   7.07 (-2.75%)
BABA   72.90 (-2.64%)
AMD   119.44 (-1.42%)
T   16.68 (+0.66%)
F   10.44 (+1.75%)
MU   76.03 (-0.12%)
CGC   0.56 (+0.34%)
GE   122.89 (+0.89%)
DIS   92.22 (-0.51%)
AMC   6.80 (+2.26%)
PFE   28.99 (-4.86%)
PYPL   58.28 (+1.16%)
XOM   103.69 (+0.92%)
S&P 500   4,561.76 (-0.13%)
DOW   35,972.66 (+0.06%)
QQQ   387.18 (-0.42%)
AAPL   190.27 (+0.17%)
MSFT   372.29 (-1.75%)
META   321.18 (-1.82%)
GOOGL   130.86 (-1.26%)
AMZN   146.09 (+0.00%)
TSLA   234.28 (-2.42%)
NVDA   465.42 (-0.49%)
NIO   7.07 (-2.75%)
BABA   72.90 (-2.64%)
AMD   119.44 (-1.42%)
T   16.68 (+0.66%)
F   10.44 (+1.75%)
MU   76.03 (-0.12%)
CGC   0.56 (+0.34%)
GE   122.89 (+0.89%)
DIS   92.22 (-0.51%)
AMC   6.80 (+2.26%)
PFE   28.99 (-4.86%)
PYPL   58.28 (+1.16%)
XOM   103.69 (+0.92%)

Edgewise Therapeutics (EWTX) Earnings Date, Estimates & Call Transcripts

$6.11
+0.03 (+0.49%)
(As of 10:50 AM ET)
Compare
Today's Range
$5.93
▼
$6.16
50-Day Range
$5.51
▼
$7.36
52-Week Range
$5.12
▼
$11.48
Volume
212,423 shs
Average Volume
198,793 shs
Market Capitalization
$387.74 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$24.00
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
Feb. 22Estimated
Actual EPS
(Nov. 9)
-$0.41 Missed By -$0.01
Consensus EPS
(Nov. 9)
-$0.40
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

EWTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

EWTX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Edgewise Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20231($0.49)($0.49)($0.49)
Q2 20232($0.51)($0.51)($0.51)
Q3 20232($0.50)($0.48)($0.49)
Q4 20232($0.56)($0.52)($0.54)
FY 20237($2.06)($2.00)($2.03)
Q1 20242($0.62)($0.41)($0.52)
Q2 20242($0.67)($0.42)($0.55)
Q3 20242($0.73)($0.44)($0.59)
Q4 20242($0.80)($0.46)($0.63)
FY 20248($2.82)($1.73)($2.28)

EWTX Earnings Date and Information

Edgewise Therapeutics last posted its quarterly earnings data on November 9th, 2023. The reported ($0.41) EPS for the quarter, missing the consensus estimate of ($0.40) by $0.01. Edgewise Therapeutics has generated ($1.42) earnings per share over the last year (($1.42) diluted earnings per share). Earnings for Edgewise Therapeutics are expected to decrease in the coming year, from ($1.56) to ($2.06) per share. Edgewise Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 22nd, 2024 based off prior year's report dates.

Edgewise Therapeutics Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
2/22/2024
Estimated)		------- 
11/9/2023Q3 2023($0.40)($0.41)($0.01)($0.41)--
8/10/2023Q2 2023($0.41)($0.34)+$0.07($0.34)--
5/11/2023Q1 2023($0.37)($0.36)+$0.01($0.36)--
2/23/2023Q4 2022($0.36)($0.31)+$0.05($0.31)--
11/3/2022Q3 2022($0.36)($0.34)+$0.02($0.34)--
8/4/2022Q2 2022($0.34)($0.32)+$0.02($0.32)--
5/11/2022Q1 2022($0.29)($0.30)($0.01)($0.30)--
2/24/2022Q4 2021($0.28)($0.26)+$0.02($0.26)--    
11/10/2021Q3 2021($0.21)($0.26)($0.05)($0.26)--
8/9/2021Q2 2021($0.17)($0.21)($0.04)($0.21)--
5/13/2021Q1 2021($0.16)($0.14)+$0.02$4.09--












Edgewise Therapeutics Earnings - Frequently Asked Questions

When is Edgewise Therapeutics's earnings date?

Edgewise Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 22nd, 2024 based off last year's report dates. Learn more on EWTX's earnings history.

Did Edgewise Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Edgewise Therapeutics (NASDAQ:EWTX) missed the analysts' consensus estimate of ($0.40) by $0.01 with a reported earnings per share (EPS) of ($0.41). Learn more on analysts' earnings estimate vs. EWTX's actual earnings.

How much profit does Edgewise Therapeutics generate each year?

Edgewise Therapeutics (NASDAQ:EWTX) has a recorded net income of -$67.64 million. EWTX has generated -$1.42 earnings per share over the last four quarters.

What is Edgewise Therapeutics's EPS forecast for next year?

Edgewise Therapeutics's earnings are expected to decrease from ($1.56) per share to ($2.06) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:EWTX) was last updated on 12/1/2023 by MarketBeat.com Staff

My Account -